PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 61 filers reported holding PTC THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $837,708 | -36.1% | 37,381 | +15.9% | 0.00% | 0.0% |
| Q2 2023 | $1,311,893 | -43.6% | 32,257 | -32.8% | 0.00% | 0.0% |
| Q1 2023 | $2,325,652 | -2.8% | 48,011 | -23.4% | 0.00% | 0.0% |
| Q4 2022 | $2,392,801 | -64.2% | 62,688 | -52.9% | 0.00% | -75.0% |
| Q3 2022 | $6,676,000 | +19.2% | 132,992 | -4.9% | 0.00% | +33.3% |
| Q2 2022 | $5,603,000 | +3.5% | 139,870 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $5,415,000 | -8.9% | 145,132 | -2.8% | 0.00% | 0.0% |
| Q4 2021 | $5,944,000 | +8.1% | 149,262 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $5,497,000 | -14.8% | 147,686 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $6,452,000 | -9.3% | 152,629 | +1.6% | 0.00% | -25.0% |
| Q1 2021 | $7,113,000 | -39.9% | 150,245 | -22.6% | 0.00% | -42.9% |
| Q4 2020 | $11,842,000 | +41.3% | 194,027 | +8.2% | 0.01% | +16.7% |
| Q3 2020 | $8,379,000 | -4.0% | 179,253 | +4.2% | 0.01% | -14.3% |
| Q2 2020 | $8,730,000 | +2.2% | 172,029 | -10.1% | 0.01% | -12.5% |
| Q1 2020 | $8,541,000 | -14.2% | 191,440 | -7.7% | 0.01% | +33.3% |
| Q4 2019 | $9,960,000 | +415.3% | 207,385 | +262.6% | 0.01% | +500.0% |
| Q3 2019 | $1,933,000 | -82.1% | 57,198 | -76.2% | 0.00% | -83.3% |
| Q2 2019 | $10,794,000 | -73.7% | 239,921 | -78.0% | 0.01% | -75.0% |
| Q1 2019 | $41,104,000 | +22.4% | 1,092,077 | +11.6% | 0.02% | 0.0% |
| Q4 2018 | $33,595,000 | +126.4% | 978,900 | +210.1% | 0.02% | +500.0% |
| Q3 2018 | $14,837,000 | +6.8% | 315,685 | -23.3% | 0.00% | 0.0% |
| Q2 2018 | $13,889,000 | -2.1% | 411,782 | -21.4% | 0.00% | -42.9% |
| Q1 2018 | $14,183,000 | +248.0% | 524,190 | +114.4% | 0.01% | +133.3% |
| Q4 2017 | $4,075,000 | +239.0% | 244,458 | +306.4% | 0.00% | +200.0% |
| Q3 2017 | $1,202,000 | -42.2% | 60,154 | -47.0% | 0.00% | 0.0% |
| Q2 2017 | $2,078,000 | +203.4% | 113,478 | +62.5% | 0.00% | 0.0% |
| Q1 2017 | $685,000 | -84.4% | 69,840 | -82.7% | 0.00% | -75.0% |
| Q4 2016 | $4,395,000 | -55.2% | 403,090 | -42.4% | 0.00% | -42.9% |
| Q3 2016 | $9,805,000 | +728.8% | 700,073 | +314.5% | 0.01% | +600.0% |
| Q2 2016 | $1,183,000 | -48.9% | 168,877 | -53.1% | 0.00% | -50.0% |
| Q1 2016 | $2,316,000 | -72.9% | 359,990 | +36.2% | 0.00% | -66.7% |
| Q4 2015 | $8,560,000 | -31.1% | 264,282 | -43.2% | 0.01% | -40.0% |
| Q3 2015 | $12,415,000 | -36.3% | 465,104 | +14.8% | 0.01% | -16.7% |
| Q2 2015 | $19,502,000 | +119.4% | 405,253 | +177.4% | 0.01% | +100.0% |
| Q1 2015 | $8,888,000 | +136.6% | 146,100 | +101.3% | 0.01% | +200.0% |
| Q4 2014 | $3,756,000 | -30.8% | 72,588 | -41.2% | 0.00% | -33.3% |
| Q3 2014 | $5,431,000 | +259.7% | 123,427 | +113.4% | 0.00% | +200.0% |
| Q2 2014 | $1,510,000 | +128.1% | 57,839 | +127.9% | 0.00% | – |
| Q1 2014 | $662,000 | -38.9% | 25,377 | -60.3% | 0.00% | -100.0% |
| Q4 2013 | $1,083,000 | +68.4% | 63,904 | +113.0% | 0.00% | – |
| Q3 2013 | $643,000 | – | 29,998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |